Literature DB >> 21073959

Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder.

Giacomo Salvadore1, Allison C Nugent, Herve Lemaitre, David A Luckenbaugh, Ruth Tinsley, Dara M Cannon, Alexander Neumeister, Carlos A Zarate, Wayne C Drevets.   

Abstract

Previous neuromorphometric investigations of major depressive disorder (MDD) have reported abnormalities in gray matter in several regions, although the results have been inconsistent across studies. Some discrepancies in the results across studies may reflect design limitations such as small sample sizes, whereas others may reflect biological variability that potentially manifests as differences in clinical course. For example, it remains unclear whether the abnormalities found in persistently depressed MDD subjects extend to or persist in patients who experience prolonged remission. The aim of the present study was to investigate gray matter (GM) differences in unmedicated, currently-depressed participants (dMDD) and unmedicated, currently-remitted (rMDD) participants with MDD compared to healthy controls (HC). The GM density and volume were compared across groups using voxel-based morphometry, a quantitative neuroanatomical technique, and high-resolution MRI images from 107 HC, 58 dMDD and 27 rMDD subjects. Relative to the HC group the dMDD group had reduced GM in the dorsal anterolateral (DALPFC), the dorsomedial (DMPFC) and the ventrolateral prefrontal cortex (VLPFC). Relative to the rMDD group the dMDD group showed reduced GM in the DALPFC, the VLPFC, the anterior cingulate cortex (ACC), the precuneus and the inferior parietal lobule. No regions were identified in which the rMDD group showed significantly lower GM compared to the HC group after p-values were corrected for the number of comparisons performed. In unmedicated patients in the depressed phase of MDD, we found evidence of morphometric abnormalities in DALPFC and in medial prefrontal cortical regions belonging to the visceromotor network. These findings, along with the absence of GM abnormalities in the remitted sample imply a possible link between greater GM tissue and better clinical outcome. Consistent with other neuroimaging and post-mortem neuropathological studies of MDD, we also found evidence of decreased white matter in patients with dMDD and rMDD. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073959      PMCID: PMC3020249          DOI: 10.1016/j.neuroimage.2010.11.011

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  37 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  Nonstationary cluster-size inference with random field and permutation methods.

Authors:  Satoru Hayasaka; K Luan Phan; Israel Liberzon; Keith J Worsley; Thomas E Nichols
Journal:  Neuroimage       Date:  2004-06       Impact factor: 6.556

3.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo; J Wei; G Dilley; S D Pittman; H Y Meltzer; J C Overholser; B L Roth; C A Stockmeier
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

4.  Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder.

Authors:  G Rajkowska; A Halaris; L D Selemon
Journal:  Biol Psychiatry       Date:  2001-05-01       Impact factor: 13.382

5.  Subgenual prefrontal cortex abnormalities in mood disorders.

Authors:  W C Drevets; J L Price; J R Simpson; R D Todd; T Reich; M Vannier; M E Raichle
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

6.  Interaction of childhood stress with hippocampus and prefrontal cortex volume reduction in major depression.

Authors:  Thomas Frodl; Elena Reinhold; Nikolaos Koutsouleris; Maximilian Reiser; Eva M Meisenzahl
Journal:  J Psychiatr Res       Date:  2010-02-01       Impact factor: 4.791

7.  Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric study.

Authors:  Cheng-Ta Li; Ching-Po Lin; Kun-Hsien Chou; I-Yun Chen; Jen-Chuen Hsieh; Chia-Liang Wu; Wei-Chen Lin; Tung-Ping Su
Journal:  Neuroimage       Date:  2009-11-26       Impact factor: 6.556

8.  A new depression scale designed to be sensitive to change.

Authors:  S A Montgomery; M Asberg
Journal:  Br J Psychiatry       Date:  1979-04       Impact factor: 9.319

9.  Functional but not structural subgenual prefrontal cortex abnormalities in melancholia.

Authors:  D A Pizzagalli; T R Oakes; A S Fox; M K Chung; C L Larson; H C Abercrombie; S M Schaefer; R M Benca; R J Davidson
Journal:  Mol Psychiatry       Date:  2004-04       Impact factor: 15.992

10.  Untreated depression and hippocampal volume loss.

Authors:  Yvette I Sheline; Mokhtar H Gado; Helena C Kraemer
Journal:  Am J Psychiatry       Date:  2003-08       Impact factor: 18.112

View more
  62 in total

1.  Altered error-related brain activity in youth with major depression.

Authors:  Cecile D Ladouceur; John S Slifka; Ronald E Dahl; Boris Birmaher; David A Axelson; Neal D Ryan
Journal:  Dev Cogn Neurosci       Date:  2012-02-08       Impact factor: 6.464

2.  Brain areas associated with resilience to depression in high-risk young women.

Authors:  Birce Begum Burhanoglu; Gulsah Dinçer; Alpaslan Yilmaz; Ozgun Ozalay; Ozgul Uslu; Esmin Unaran; Omer Kitis; Ali Saffet Gonul
Journal:  Brain Struct Funct       Date:  2021-01-17       Impact factor: 3.270

Review 3.  Stress, depression and Parkinson's disease.

Authors:  Ann M Hemmerle; James P Herman; Kim B Seroogy
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

4.  Cortical thinning in patients with late-life minor depression.

Authors:  Anand Kumar; Olusola Ajilore; Aifeng Zhang; Daniel Pham; Virginia Elderkin-Thompson
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

5.  Concurrent functional and structural cortical alterations in migraine.

Authors:  Nasim Maleki; Lino Becerra; Jennifer Brawn; Marcelo Bigal; Rami Burstein; David Borsook
Journal:  Cephalalgia       Date:  2012-05-23       Impact factor: 6.292

6.  Blockade of astrocytic glutamate uptake in the prefrontal cortex induces anhedonia.

Authors:  Catherine S John; Karen L Smith; Ashlee Van't Veer; Heinrich S Gompf; William A Carlezon; Bruce M Cohen; Dost Öngür; Anita J Bechtholt-Gompf
Journal:  Neuropsychopharmacology       Date:  2012-06-27       Impact factor: 7.853

Review 7.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Authors:  P Licznerski; R S Duman
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

Review 8.  Migraine: maladaptive brain responses to stress.

Authors:  Nasim Maleki; Lino Becerra; David Borsook
Journal:  Headache       Date:  2012-10       Impact factor: 5.887

9.  Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.

Authors:  Stéphane P Poulin; David Bergeron; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 10.  Psychoradiology: The Frontier of Neuroimaging in Psychiatry.

Authors:  Su Lui; Xiaohong Joe Zhou; John A Sweeney; Qiyong Gong
Journal:  Radiology       Date:  2016-11       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.